Showing results (1-10 of 215) with videos related to
Sort By:
Pageof 22
The Egyptian Journal of Immunology|November 10, 2017
IL-17 Induced The Recruitment and Functional Activity of Granulocytes Isolated from Patients Coinfected with Schistosoma mansoni and Hepatitis C VirusSoad Nady, Gamal EsmatJournal of Advanced Research|February 17, 2015
Hepatic and intestinal schistosomiasis: reviewTamer Elbaz, Gamal EsmatArab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|May 21, 2014
Antischistosomal therapy: Current status and recent developmentsGamal Esmat, Maissa El RazikyArab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|March 16, 2026
Three decades of change: schistosomiasis, hepatitis C, and the rise of metabolic dysfunction-associated steatotic liver disease in EgyptMohamed El-Kassas, Gamal EsmatJournal of Advanced Research|August 11, 2015
New era for management of chronic hepatitis C virus using direct antiviral agents: A reviewTamer Elbaz, Mohamed El-Kassas, Gamal EsmatJournal of Advanced Research|February 17, 2015
Human schistosomiasis: clinical perspective: reviewRashad S Barsoum, Gamal Esmat, Tamer El-BazExpert Opinion on Drug Safety|September 24, 2016
Safety of direct antiviral agents in the management of hepatitis CMohamed El Kassas, Tamer Elbaz, Enas Hafez, et al.Current Drug Discovery Technologies|July 15, 2017
A New Potent NS5A Inhibitor in the Management of Hepatitis C Virus: RavidasvirEnas Hafez, Tamer Elbaz, Mohamed El Kassas, et al.Expert Opinion on Pharmacotherapy|November 12, 2022
Daclatasvir as a hepatitis C infection treatment option: an up-to-date evaluationNirmeen Sabry, Ahmed M Kamel, Ahmed Cordie, et al.Expert Review of Clinical Pharmacology|September 8, 2016
Elbasvir and grazoprevir for chronic hepatitis C genotypes 1 and 4Mohamed El Kassas, Tamer Elbaz, Yasmeen Abd El Latif, et al.Pageof 22